Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChamberlin Plc Share News (CMH)

  • This share is currently suspended. It was suspended at a price of 1.18

Share Price Information for Chamberlin Plc (CMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.18
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.18
CMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps: Titon, Utd Drug, Vernalis...

Thu, 29th Jul 2010 14:16

Blinds specialist Titon's revenues for the 3 months to June were 19% higher than the corresponding period last year, with UK sales 15% higher and the rest of the world 37% higher. Growth in the UK came from higher sales of mechanical ventilation systems. There were also increased sales volumes in South Korea. With 80% of sales emanating in the UK and with most other export markets showing little sign of recovery from the recession, Titon remains cautious about the short-term outlook.United Drug reports trading since April has been satisfactory, with a strong performance in parts of the business. Group profits for the nine months to 30 June were in line with last year, as expected, and cash flows continue to be strong throughout the group. Based on trading for the year to date, profits before tax for the year to 30 September should be broadly in line with last year.Drug developer Vernalis upped first half revenue by 26% to £7.2m (2009: £5.7m), with its operating loss reduced to £1.1m from £5.3m. Underlying cash burn reduced to £2.7m (2009: £8.2m).Stockbroker Charles Stanley grew revenue by 11.2% to £28.9m in its first quarter, although total client funds under investment management and administration fell 4.7% to £12.2bn in the three months ended 30 June.The update was accompanied by news that finance director Peter Hurst is hanging up his boots after 24 years in the same job. He'll retire some time in the middle of next year. Engineer Chamberlin has kept its strong run going after confirming first quarter business has been strong across all three of its foundries."With the improving demand, a reduced cost base and production capability intact, the board continues to be confident of a return to profitability in the year and views prospects very positively," chairman Tom Brown said in his AGM statement.Stockbroker Collins Stewart had a "solid" first half, although operating profit fell 8% at the wealth management business after a £0.5m one-off cost linked to acquisitions.Overall operating profit rose 20% to £7.3m on revenue £0.8m higher at £96.1m. Profit before tax added 7% to £6.5m, while assets under management have risen 15% since the end of 2009 to £6.8bn."The group has been turned around and is generally making progress in difficult markets," said boss Mark Brown. "The full benefits of previous investment are still to come through and our strong financial position will enable us to continue to invest as opportunities arise."Getech, a provider of geological data to assist with oil exploration, has continued the trend towards recovery during the second half of its current financial year.The first half loss of £392,000 will result in a deficit for the full-year, although there's likely to be an operating profit for the six months to 31 July. Production was down 17% at 30,236 ounces at gold miner Centamin Egypt between the fourth and third quarters due to lower-than-expected grade, although full-year guidance is kept at 200,000 ounces.Analysts at Ambrian are still backing the shares. They say all price drivers remain fully intact and strongly recommend buying into any weakness, although a further drop in production against forecast could create price pressure.Stem cell group Epistem reports strong growth in all divisions and in net profits, and says full-year results will be in line with forecasts. KBC Peel Hunt is happy with the update. The broker sees several near term catalysts, so keeps its 'buy' rating and 515p target price. More news on the collaboration with Novartis could provide scope for an upgrade, it says.A focus on internal efficiencies ensured cake and bread supplier Finsbury Food delivered profit in line with expectations despite a 9.7% decline in like for like sales at the cake division.The firm blamed a 4.1% drop in revenue to £168.3m on consumers trading down and more frequently choosing products on promotion.Panmure Gordon still thinks investors should tuck in. It's reassured by a rephrasing of £5m of deferred consideration, which eases pressure on cash flow, and confirmation that the group is operating fully within existing banking facilities. It keeps a 'buy' recommendation and 30p target price.The share price of sweets and cakes maker Lees Foods surged to a 52-week high after it said demand for its products continues to be strong, with both Lees of Scotland and The Waverley Bakery achieved record sales for the first half of the year.Pre-tax profits for the first six months of 2010 are set to be significantly ahead of last year, while group sales have risen to £9.62m from £8.85m the year before. The company remains cautiously optimistic in respect of the second half of the year and expects that both sales and pre-tax profits will be ahead of market forecasts for the full year.Interactive gaming company NetplayTV said a new format and schedule of its Challenge Jackpot and Bingo Stars offerings on ITV are scheduled to go live tonight (Thursday), which the company hopes will ginger up the response, which has thus far been disappointing.The company's core Supercasino.com business has seen improved depositing sign ups over the last month, as well as an increase in player numbers month on month, as a result of renewed focus on this brand. "We have however been impacted by a number of large winners reducing the gaming margin for July to 1.3% against an average for the year of 3%," the company said.
More News
9 Sep 2013 12:10

DIRECTOR DEALINGS - Chamberlin Finance Director Buys 5K Shares

Read more
13 Aug 2013 16:22

Int'l Personal Finance FD sells shares

David Broadbent, the Finance Director of home credit firm International Personal Finance (IPF), has sold a small stake in the firm after exercising options. Broadbent, who has been in his position since 2007, exercised a total of 65,575 share options under the company's share option plan and perfor

Read more
18 Jul 2013 08:41

Profit warning sends Chamberlin shares tumbling

Shares in Chamberlin plummeted after the engineering and foundry group warned full year profits would be materially below expectations. It said the first half of the financial year had been "tough" especially at its foundries in Leicester and Scunthorpe after an expected recovery in demand in their

Read more
18 Jul 2013 08:40

STOCKS NEWS EUROPE-UK small caps underperform blue-chips

The FTSE Small Caps Index is up 0.1 percent in early session trading while the FTSE Aim All-Share Index is flat, with both underperforming a 0.3 percent rise in the blue-chip FTSE 100 index while the FTSE 250 mid-cap index is up by 0.3 percent. Chamberlin, a specialist foundry and engineeri

Read more
26 Apr 2013 13:02

Engineering group Chamberlin advances on positive trading update

Chamberlin, the AIM-listed specialist foundry and engineering group, expects to deliver pre-tax profits for the full year in line with current market expectations of approximately 1.3m pounds. In an update on trading for the financial year to March 31st, ahead of its financial results which are due

Read more
28 Jan 2013 08:01

Chamberlin warns on full year profit

Shares of engineering firm Chamberlin sank after it warned pre-tax profits are expected to come in below current market forecasts for the full year as market conditions in several of is sectors softened materially. "At half year results, we reported that there were uncertainties to the general econ

Read more
10 Dec 2012 16:25

Chamberlin Chairman invests 75k

Castings and engineering group Chamberlin announced on Monday that its Chairman has topped up his stake in the company twice over the couple of weeks. Keith Butler-Wheelhouse acquired a total of 44,500 Chamberlin ordinary shares through his family trust, BW Family Limited (BWFL), representing 0.56%

Read more
27 Jul 2012 15:50

Synergy CEO stocks up as Q1 growth limited by currency

Dr Richard Steeves, the Chief Executive Officer of Synergy Health, a provider of outsourced sterilisation services, bought himself a round of shares on the same day the firm admitted headline growth in the first quarter had been held back by currency translation with the devaluation of the euro. T

Read more
12 Jul 2012 15:54

Small caps round-up: Biome, Ceramic Fuel Cells, Chamerlin

Technology group Biome has seen significant positive developments in the patent litigation cases currently being heard against its joint venture company, Biotec. The claims, which are being made by Italian company Novamont, are for infringement of the French and Italian designations of a number of N

Read more
22 May 2012 13:05

Brokers queue up to praise Chamberlin

Engineering firm Chamberlin said revenue and earnings are now at higher levels than they were before the recession bit in the last decade. Exports drove revenue growth, with turnover up 14% to £45.5m in the year to March 31st from £39.8m the year before. That was a shade below the £46m expected by

Read more
22 May 2012 09:26

Tuesday broker round-up - UPDATE

Chamberlin: Charles Stanley maintains buy rating and 175p target. easyJet: Investec upgrades from hold to buy, target hiked from 500p to 670p. HomeServe: Charles Stanley cuts target from 290p to 250p, rating under review; Jefferies maintains underperform rating and 195p target. Inmarsat: UBS cut

Read more
29 Nov 2011 09:15

Tuesday broker round-up - UPDATE

Senior: Credit Suisse keeps at neutral, raises target to 175p from 165p. Icap: Credit Suisse keeps at outperform, lowers target to 420p from 510p. G4S: HSBC upgrades to overweight from neutral. Rio Tinto: UBS cuts target from 6,000p to 5,650p, buy rating kept [28 November]. BP: Nomura keeps neut

Read more
29 Nov 2011 08:36

London open: Miners and banks prove a drag

Investors are generally holding their fire ahead of this afternoon's Autumn statement from the Chancellor of the Exchequer, George Osborne. The Footsie gives back a few of the gains made yesterday, largely as a result of the weakness of miners, while banks are also off the boil. PUTTING ON A SHOW

Read more
29 Nov 2011 08:23

Chamberlin revenue jumps 25%

Specialist castings and engineering group Chamberlin said half yearly revenue rose by a quarter and it expects full year results to be in line with current market forecasts. Revenues rose to £23m for six months ended 30 September 2011 from £18.3m a year earlier. The maker of safety and security pr

Read more
11 Oct 2011 07:32

Chamberlin on track for full year

Castings and engineering group Chamberlin said trading in the first half of the financial year has been in line with management forecasts. The group, which makes metal products such as door handles and steering wheel components, said order flow across core foundry activities has reflected predicte

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.